Bernstein H H, Chitkara U, Plosker H, Gettes M, Berkowitz R L
Department of Anesthesia, Mount Sinai School of Medicine, New York, New York.
Obstet Gynecol. 1988 Nov;72(5):813-6.
Prevention of movement during intrauterine transfusion is important to facilitate the procedure and to prevent injury to the fetus. We administered atracurium besylate to the fetus via the umbilical vein during 12 intrauterine intravascular transfusions. A dose of 0.2-0.4 mg/kg of estimated fetal weight was administered after needle entry into the umbilical vein. With a dose of 0.2 mg/kg, fetal movement was slowed transiently. Thereafter, 0.4 mg/kg was administered. All recipients were paralyzed for the duration of the procedure. Fetal activity returned 20-130 minutes later.
在宫内输血过程中防止胎儿活动对于顺利进行该操作以及防止胎儿受伤很重要。在12例宫内血管内输血过程中，我们通过脐静脉给胎儿注射了阿曲库铵苯磺酸盐。在针头进入脐静脉后，按估计胎儿体重给予0.2 - 0.4毫克/千克的剂量。给予0.2毫克/千克的剂量后，胎儿活动暂时减缓。此后，又给予了0.4毫克/千克的剂量。所有受血者在操作过程中均处于麻痹状态。胎儿活动在20 - 130分钟后恢复。
